Chinese oral care brand NYSCPS has raised nearly $62 million led by Huaxing Growth Capital. In a separate development, Sherpa Healthcare Partners has led a $30-million Series A round in the US-based biotech firm PAQ Therapeutics.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
